{{Rsnum
|rsid=7044343
|Gene=IL33
|Chromosome=9
|position=6254208
|Orientation=plus
|GMAF=0.4977
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 14.8 | 50.0 | 35.2
| HCB | 21.1 | 52.6 | 26.3
| JPT | 24.4 | 36.6 | 39.0
| YRI | 60.3 | 34.5 | 5.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 21.1 | 52.6 | 26.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20708824
|Title=Implication of IL-33 gene polymorphism in Chinese patients with Alzheimer's disease
}}

{{PMID|19204726|OA=1
}} Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease.

{{PMID Auto
|PMID=24779919
|Title=Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}